Related Experiment Video
Updated: Jun 12, 2025
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Seronegative Myasthenia Gravis: A Rare Disease Triggered by SARS-CoV-2 or a Coincidence?
Beatriz Castro Silva1, Miguel Saianda Duarte2, Nuno Rodrigues Alves3
1Internal Medicine, Hospital Beatriz Ângelo, Loures, PRT.
Abstract:
Myasthenia gravis (MG) results from the production of autoantibodies against the neuromuscular junction, leading to muscle weakness. Although the exact cause is not fully understood, it is known that the onset and exacerbations of MG can occur after viral infections. We present the case of a patient with no prior history of MG with new-onset proximal muscle weakness and ptosis, following SARS-CoV-2 infection, This case underscores the potential for autoimmune diseases to be triggered by SARS-CoV-2.
Insights
Myasthenia gravis (MG), an autoimmune condition causing muscle weakness, can be triggered by viral infections. A recent case highlights SARS-CoV-2 as a potential trigger for new-onset MG, emphasizing the link between viral infections and autoimmune diseases.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions, causing muscle weakness.
- Viral infections are known triggers for MG onset and exacerbations.
- The precise mechanisms linking viral infections to MG remain under investigation.
Observation:
- A patient with no prior history of myasthenia gravis developed new-onset symptoms following SARS-CoV-2 infection.
- The patient presented with proximal muscle weakness and ptosis.
- These symptoms are indicative of neuromuscular junction dysfunction.
Findings:
- The case suggests a potential causal link between SARS-CoV-2 infection and the development of myasthenia gravis.
- Autoantibody production against the neuromuscular junction is the hallmark of myasthenia gravis.
- SARS-CoV-2 infection may act as a precipitating factor for autoimmune processes in susceptible individuals.
Implications:
- This case underscores the potential for SARS-CoV-2 to trigger autoimmune diseases, including myasthenia gravis.
- Further research is warranted to elucidate the immunological pathways involved.
- Understanding these triggers can inform clinical management and preventative strategies for post-infectious autoimmune conditions.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...